5-141945390-C-CCTGCTGCTG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_016580.4(PCDH12):c.3537_3545dupCAGCAGCAG(p.Ser1179_Ser1181dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,550,564 control chromosomes in the GnomAD database, including 86,754 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 13105 hom., cov: 0)
Exomes 𝑓: 0.39 ( 73649 hom. )
Consequence
PCDH12
NM_016580.4 disruptive_inframe_insertion
NM_016580.4 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.71
Genes affected
PCDH12 (HGNC:8657): (protocadherin 12) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein consists of an extracellular domain containing 6 cadherin repeats, a transmembrane domain and a cytoplasmic tail that differs from those of the classical cadherins. The gene localizes to the region on chromosome 5 where the protocadherin gene clusters reside. The exon organization of this transcript is similar to that of the gene cluster transcripts, notably the first large exon, but no significant sequence homology exists. The function of this cellular adhesion protein is undetermined but mouse protocadherin 12 does not bind catenins and appears to have no affect on cell migration or growth. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 5-141945390-C-CCTGCTGCTG is Benign according to our data. Variant chr5-141945390-C-CCTGCTGCTG is described in ClinVar as [Benign]. Clinvar id is 768040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.787 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH12 | NM_016580.4 | c.3537_3545dupCAGCAGCAG | p.Ser1179_Ser1181dup | disruptive_inframe_insertion | 4/4 | ENST00000231484.4 | NP_057664.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH12 | ENST00000231484.4 | c.3537_3545dupCAGCAGCAG | p.Ser1179_Ser1181dup | disruptive_inframe_insertion | 4/4 | 1 | NM_016580.4 | ENSP00000231484.3 |
Frequencies
GnomAD3 genomes AF: 0.410 AC: 61041AN: 149040Hom.: 13098 Cov.: 0
GnomAD3 genomes
AF:
AC:
61041
AN:
149040
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.388 AC: 543171AN: 1401410Hom.: 73649 Cov.: 59 AF XY: 0.390 AC XY: 271522AN XY: 696896
GnomAD4 exome
AF:
AC:
543171
AN:
1401410
Hom.:
Cov.:
59
AF XY:
AC XY:
271522
AN XY:
696896
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.409 AC: 61073AN: 149154Hom.: 13105 Cov.: 0 AF XY: 0.418 AC XY: 30434AN XY: 72876
GnomAD4 genome
AF:
AC:
61073
AN:
149154
Hom.:
Cov.:
0
AF XY:
AC XY:
30434
AN XY:
72876
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 26, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
PCDH12-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 10, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Diencephalic-mesencephalic junction dysplasia syndrome 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at